English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Hip fracture is one of the most common risk factors increasing the mortality rate among the elderly population, especially in the first year after injury even when receiving operative treatment to encourage early ambulation. Objective: To compare one year mortality rate between patients with anti-osteoporosis therapy and those without anti-osteoporotic medication after surgical intervention for hip fracture. Method: 156 patients underwent surgical intervention for hip fractures from low energy trauma were reviewed. Demographic data, comorbidity, and anti-osteoporotic medication were collected. Patients were classified into 2 groups: Patients taking antiosteoporotic drug and those who did not receive anti-osteoporotic drug. Statistical significance was identified by P-value less than 0.05. Results: The rate of osteoporosis treatment in patients sustained hip fracture was low (48%). Prevalence of one year mortality rate underwent surgical intervention was 15.4% (6.7% vs 23.5% in the treated and untreated groups, respectively, p=0.004).Patients with a history of anti-osteoporotic drug intake tended to receive osteoporotic drugs after treatment (P<0.001). In univariate analysis, there were several factors that significantly affected one year mortality including age (P=0.001), history of kidney disease (P=0.049), ambulatory status on the day discharged from the hospital (P=0.028) and history of osteoporotic drug intake (P=0.004). Recurrent fracture was not significantly related to one year mortality rate in these patients. Conclusion: After surgical treatment of osteoporotic hip fracture, one year mortality rate tended to decrease among patients receiving anti-osteoporotic drugs. Physicians should promote osteoporosis therapy in all patients who have sustained hip fracture in the elderly population.

Comparative One Year Mortality Rate between Treated and Untreated For Osteoporosis Therapy after Surgical Intervention for Hip Fracture